MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma (Q30436031)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma |
scientific article |
Statements
1 reference
MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma (English)
1 reference
Craig L Slingluff
1 reference
Kimberly A Chianese-Bullock
1 reference
Jennifer Pressley
1 reference
Courtney Garbee
1 reference
Sarah Hibbitts
1 reference
Cheryl Murphy
1 reference
Galina Yamshchikov
1 reference
Gina R Petroni
1 reference
Eric A Bissonette
1 reference
Patrice Y Neese
1 reference
William W Grosh
1 reference
Priscilla Merrill
1 reference
Robyn Fink
1 reference
Elizabeth M H Woodson
1 reference
Catherine J Wiernasz
1 reference
James W Patterson
1 reference
1 March 2005
1 reference
1 reference
174
1 reference
3080-3086
1 reference
Identifiers
1 reference
1 reference